Oropharynx (OPX) Salivary Biomarker Study

NCT05093400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-07-07

No results posted yet for this study

Summary

The goal of this study is to analyze certain biomarkers to look at the relationship between HPV in the saliva, stage at presentation, and a potential self-test compared to saliva of non-cancerous participants.

Conditions

  • Healthy

Interventions

OTHER

no intervention

saliva collection

Sponsors & Collaborators

Principal Investigators

  • Kathryn Van Abel, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-17
Primary Completion
2023-05-02
Completion
2023-05-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05093400 on ClinicalTrials.gov